Massachusetts-based Intrinsic Therapeutics is nearing the close of a $20.9 million equity round, with about $17.3 million raised so far.
Funding Roundup
Funding: InSightec raises $12.5M from Chinese backers
Israeli device maker InSightec added $12.5 million to its coffers thanks to the support of Chinese backers, the firm’s parent company announced.
Corindus raises $26.6M for vascular robot
Massachusetts-based Corindus Vascular Robotics has big plans for its newly secured $26.6 million, raised in a private placement funding round.
Corindus sold nearly 10.7 million shares at $2.50 apiece through a Securities Purchase Agreement, with Cowen & Co. and Stifel, Nicolaus & Co. acting as placement agents.
Medigus raises $5.6M, touts clinical results for acid reflux device
ReWalk Robotics prices IPO at $36M, below range
ReWalk Robotics (NSDQ:RWLK) priced its initial public offering below its forecast range, at $12 per share, grossing some $36.0 million for its exo-skeleton suit.
Fractyl raises $40 million in support of ablation-based approach to type 2 diabetes | Medtech funding for the week of September 8, 2014
Mevion Medical files for $69M IPO
Harpoon Medical raises $3.8M for mitral valve device
Harpoon Medical is looking to move from concept to the clinic with the $3.8 million it raised in its Series A funding round in support of its mitral repair devices.
Tryton Medical raises $20M for side-branch stent trial
Tryton Medical said today that’s made an initial closing on a $20 million private equity round from existing and new investors.
Diabetes: Fractyl raises $40M, touts positive early results for ablation-based diabetes therapy
Massachusetts medical device maker Fractyl announced this week that it raised $40 million in support of its ablation-based approach to type 2 diabetes, which looks promising in early studies.
eNeura raises $5.8M for home migraine device
Maryland-based migraine devices maker eNeura is closing in on a $6.6 million funding round, with $5.8 million raised so far.